Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125589571 | 12558957 | 1 | I | 20160701 | 20160715 | 20160715 | EXP | JP-ROCHE-1793578 | ROCHE | TOSHIMA H, HISAMATSU A, SHIMADA K, SAITO M, SUZUKI M, MATSUKAWA M AND INOUE H A CASE OF HER2-POSITIVE ESOPHAGOGASTRIC JUNCTION CANCER WITH PERFORATION CURATIVELY RESECTED AFTER NEOADJUVANT CHEMOTHERAPY PLUS TRASTUZUMAB. GAN TO KAGAKU RYOHO. CANCER AND CHEMOTHERAPY 2016 JUN;43 (6):761-764. | 60.00 | YR | M | Y | 56.10000 | KG | 20160715 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125589571 | 12558957 | 1 | PS | Trastuzumab | TRASTUZUMAB | 1 | Unknown | U | 103792 | 448.8 | MG | Q3W | |||||||
| 125589571 | 12558957 | 2 | SS | Trastuzumab | TRASTUZUMAB | 1 | Unknown | U | 103792 | 336.6 | MG | ||||||||
| 125589571 | 12558957 | 3 | SS | Trastuzumab | TRASTUZUMAB | 1 | Unknown | U | 103792 | 340 | MG | Q3W | |||||||
| 125589571 | 12558957 | 4 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | DAY 1 AND DAY 14 | Y | 20896 | 3000 | MG | |||||||
| 125589571 | 12558957 | 5 | SS | CDDP | CISPLATIN | 1 | Unknown | 80 MG/M2 | U | 0 | 130 | MG | |||||||
| 125589571 | 12558957 | 6 | SS | CDDP | CISPLATIN | 1 | Unknown | 60 MG/M2 | U | 0 | 90 | MG | |||||||
| 125589571 | 12558957 | 7 | C | TS-1 | GIMERACILOTERACILTEGAFUR | 1 | Unknown | 0 | 120 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125589571 | 12558957 | 1 | Gastrooesophageal cancer |
| 125589571 | 12558957 | 4 | Gastrooesophageal cancer |
| 125589571 | 12558957 | 5 | Gastrooesophageal cancer |
| 125589571 | 12558957 | 7 | Gastrooesophageal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125589571 | 12558957 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125589571 | 12558957 | Decreased appetite | |
| 125589571 | 12558957 | Fatigue | |
| 125589571 | 12558957 | Tumour perforation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |